Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database

NCT02863978 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 746

Last updated 2022-12-14

No results posted yet for this study

Summary

Each year, 300 000 new borns are hospitalised in neonatology units in Europe. This period is very sensitive as newborns are exposed to a high risk of morbidity and mortality, with severe impact on neuro-developmental prognostic. The Rennes University Hospital was granted a specific funding from the European Union in the framework of the Horizon 2020 programme (Call PERSONALISING HEALTH AND CARE 2015-single-stage - Grant Agreement Number 689260) to develop the Digi-NewB project. This project aims to develop innovative non-invasive monitoring tools to support decision making in health. Such tools include a new generation of real time monitoring in neonatology using composite indices made of cardio-respiratory variables, movements, sounds, and clinical data. The Digi-NewB cohort aims to gather all physiological data relevant for the creation of the composite indices.

Conditions

  • Infant, Premature

Interventions

OTHER

Multimodal signal acquisitions

Cardiac and respiratory signals are collected from the clinical monitoring routinely gathered in hospital neonatal units. Movement quantification and baby's sounds are extracted thanks to a dedicated system which will collect images and sound with microphones and cameras.

Sponsors & Collaborators

  • European Union

    collaborator OTHER
  • GCS Hôpitaux Universitaires Grand-Ouest

    collaborator UNKNOWN
  • Rennes 1 University

    collaborator UNKNOWN
  • Tampere University of Technology

    collaborator OTHER
  • Voxygen Health

    collaborator UNKNOWN
  • INESC TEC Porto

    collaborator UNKNOWN
  • National University of Ireland, Galway, Ireland

    collaborator OTHER
  • Synchrophi Systems Ltd

    collaborator UNKNOWN
  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Patrick PLADYS, MD, PhD · CHU Rennes

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
6 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-08
Primary Completion
2020-06-10
Completion
2024-06-10

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02863978 on ClinicalTrials.gov